A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al. · Journal of Gastrointestinal Surgery · 2000 · 1.5K citations

Medicine, Oncology, Surgery +12

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

C G Moertel, Stephen Frytak, R. G. Hahn et al. · Cancer · 1981 · 1K citations

Medicine, Oncology, Radiation Oncology +13

Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1

JNCI Journal of the National Cancer Institute · 1988 · 580 citations

Medicine, Oncology, Surgery +11

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 441 citations

Medicine, Oncology, Pharmacology +11